According to the new research report published by Precedence Research, titled “Non-Invasive Blood Glucose Monitoring System Market (By Technology: Spectroscopy, Electromagnetic, Microwave, Ultrasonic, Thermal, Others; By End User: Hospitals, Homecare, Clinics; By Modality: Non wearable, Wearable, Invasive, Non-invasive; By Distribution Channel: Retail sales, Institutional sales) – Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2022-2030 (By Product: Traditional, Advanced; By Application: Pottery, Tiles, Abrasives, Sanitary wave, Bricks & pipes, Others; By End User: Medical, Industrial, Building & Construction, Others) – Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2022-2030”, the global non-invasive blood glucose monitoring system market size is expected to be worth around US$ 129.75 million by 2030 and is poised to record a yearly growth rate of 25% from 2022 to 2030. The study investigates several elements and their consequences on the growth of the all-wheel drive market.
This report focuses on non-invasive blood glucose monitoring system market volume and value at the global level, regional level and company level. From a global perspective, this report represents the overall non-invasive blood glucose monitoring system market size by analysing historical data and future prospects. Regionally, this report focuses on several key regions: North America, Europe, the Middle East & Africa, Latin America, etc.
The research report includes specific segments by region (country), by company, by all segments. This study provides information about the growth and revenue during the historic and forecasted period of 2017 to 2030. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Download a Free Copy of Our Latest Sample Report@ https://www.precedenceresearch.com/sample/2405
The study also provides important advancements in organic and inorganic growth strategies in the worldwide non-invasive blood glucose monitoring system market. A lot of corporations are prioritizing new launches, product approvals, and other business expansion techniques. In addition, the report offers profiles of non-invasive blood glucose monitoring system market firms and market strategies. Furthermore, the research focuses on top industry participants, providing information such as company profiles, components and services offered, recent financial data, and key developments.
Non-Invasive Blood Glucose Monitoring System Market Report Scope
| Report Coverage | Details |
| Market Size in 2022 | USD 21.76 Million |
| Market Size by 2030 | USD 129.75 Million |
| Growth Rate from 2022 to 2030 | CAGR of 25% |
| Base Year | 2021 |
| Forecast Period | 2022 to 2030 |
| Segments Covered |
|
Also read: U.S. Corporate Wellness Market Size to Worth US$ 34.27 Billion by 2030
Market Key Players
Company profiles have been included in the report, which include essentials such as product portfolio, key strategies, along with all-inclusive SWOT analysis on each player. Company presence is mapped and presented through a matrix for all the prominent players, thus providing readers with actionable insights, which helps in thoughtfully presenting market status and predicting the competition level in the non-invasive blood glucose monitoring system market.
Some of the prominent players in the non-invasive blood glucose monitoring system market include
- Abbott Laboratories
- Medtronic plc
- F. Hoffmann-La Roche Ltd.
- Ascensia Diabetes Care
- Dexcom, Inc.
- Sanofi Novo Nordisk
- Insulet Corporation
- Ypsomed Holdings
- Glysens Incorporated
Non-Invasive Blood Glucose Monitoring System Market Segmentations
By Technology
- Spectroscopy
- Electromagnetic
- Microwave
- Ultrasonic
- Thermal
- Others
By End User
- Hospitals
- Homecare
- Clinics
By Modality
- Non wearable
- Wearable
- Invasive
- Non-invasive
By Distribution Channel
- Retail sales
- Institutional sales
By Geography
- North America
- Europe
- Asia-Pacific
- Latin America
- Middle East & Africa (MEA)
Report Objectives
- To define, segment, and project the global market size for non-invasive blood glucose monitoring system market
- To understand the structure of the market by identifying its various sub-segments
- To provide detailed information about the key factors influencing the growth of the market (drivers, restraints, opportunities, and industry-specific challenges)
- To analyse the micro-markets, with respect to individual growth trends, future prospects, and their contributions to the total market
- To project the size of the market and its submarkets, in terms of value, with respect to global. (along with their respective key countries)
- To profile key players and comprehensively analyse their core competencies
- To understand the competitive landscape and identify major growth strategies adopted by players across the globe.
- To analyse the competitive developments such as expansions & investments, new product launches, mergers & acquisitions, joint ventures, and agreements
TABLE OF CONTENT
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Non-Invasive Blood Glucose Monitoring System Market
5.1. COVID-19 Landscape: Non-Invasive Blood Glucose Monitoring System Industry Impact
5.2. COVID 19 – Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Non-Invasive Blood Glucose Monitoring System Market, By Technology
8.1. Non-Invasive Blood Glucose Monitoring System Market, by Technology, 2022-2030
8.1.1. Spectroscopy
8.1.1.1. Market Revenue and Forecast (2017-2030)
8.1.2. Electromagnetic
8.1.2.1. Market Revenue and Forecast (2017-2030)
8.1.3. Microwave
8.1.3.1. Market Revenue and Forecast (2017-2030)
8.1.4. Ultrasonic
8.1.4.1. Market Revenue and Forecast (2017-2030)
8.1.5. Thermal
8.1.5.1. Market Revenue and Forecast (2017-2030)
8.1.6. Others
8.1.6.1. Market Revenue and Forecast (2017-2030)
Chapter 9. Global Non-Invasive Blood Glucose Monitoring System Market, By End User
9.1. Non-Invasive Blood Glucose Monitoring System Market, by End User, 2022-2030
9.1.1. Others
9.1.1.1. Market Revenue and Forecast (2017-2030)
9.1.2. Homecare
9.1.2.1. Market Revenue and Forecast (2017-2030)
9.1.3. Homecare
9.1.3.1. Market Revenue and Forecast (2017-2030)
Chapter 10. Global Non-Invasive Blood Glucose Monitoring System Market, By Modality
10.1. Non-Invasive Blood Glucose Monitoring System Market, by Modality, 2022-2030
10.1.1. Homecare
10.1.1.1. Market Revenue and Forecast (2017-2030)
10.1.2. Homecare
10.1.2.1. Market Revenue and Forecast (2017-2030)
10.1.3. Invasive
10.1.3.1. Market Revenue and Forecast (2017-2030)
10.1.4. Non-invasive
10.1.4.1. Market Revenue and Forecast (2017-2030)
Chapter 11. Global Non-Invasive Blood Glucose Monitoring System Market, By Distribution Channel
11.1. Non-Invasive Blood Glucose Monitoring System Market, by Distribution Channel, 2022-2030
11.1.1. Retail sales
11.1.1.1. Market Revenue and Forecast (2017-2030)
11.1.2. Institutional sales
11.1.2.1. Market Revenue and Forecast (2017-2030)
Chapter 12. Global Non-Invasive Blood Glucose Monitoring System Market, Regional Estimates and Trend Forecast
12.1. North America
12.1.1. Market Revenue and Forecast, by Technology (2017-2030)
12.1.2. Market Revenue and Forecast, by End User (2017-2030)
12.1.3. Market Revenue and Forecast, by Modality (2017-2030)
12.1.4. Market Revenue and Forecast, by Distribution Channel (2017-2030)
12.1.5. U.S.
12.1.5.1. Market Revenue and Forecast, by Technology (2017-2030)
12.1.5.2. Market Revenue and Forecast, by End User (2017-2030)
12.1.5.3. Market Revenue and Forecast, by Modality (2017-2030)
12.1.5.4. Market Revenue and Forecast, by Distribution Channel (2017-2030)
12.1.6. Rest of North America
12.1.6.1. Market Revenue and Forecast, by Technology (2017-2030)
12.1.6.2. Market Revenue and Forecast, by End User (2017-2030)
12.1.6.3. Market Revenue and Forecast, by Modality (2017-2030)
12.1.6.4. Market Revenue and Forecast, by Distribution Channel (2017-2030)
12.2. Europe
12.2.1. Market Revenue and Forecast, by Technology (2017-2030)
12.2.2. Market Revenue and Forecast, by End User (2017-2030)
12.2.3. Market Revenue and Forecast, by Modality (2017-2030)
12.2.4. Market Revenue and Forecast, by Distribution Channel (2017-2030)
12.2.5. UK
12.2.5.1. Market Revenue and Forecast, by Technology (2017-2030)
12.2.5.2. Market Revenue and Forecast, by End User (2017-2030)
12.2.5.3. Market Revenue and Forecast, by Modality (2017-2030)
12.2.5.4. Market Revenue and Forecast, by Distribution Channel (2017-2030)
12.2.6. Germany
12.2.6.1. Market Revenue and Forecast, by Technology (2017-2030)
12.2.6.2. Market Revenue and Forecast, by End User (2017-2030)
12.2.6.3. Market Revenue and Forecast, by Modality (2017-2030)
12.2.6.4. Market Revenue and Forecast, by Distribution Channel (2017-2030)
12.2.7. France
12.2.7.1. Market Revenue and Forecast, by Technology (2017-2030)
12.2.7.2. Market Revenue and Forecast, by End User (2017-2030)
12.2.7.3. Market Revenue and Forecast, by Modality (2017-2030)
12.2.7.4. Market Revenue and Forecast, by Distribution Channel (2017-2030)
12.2.8. Rest of Europe
12.2.8.1. Market Revenue and Forecast, by Technology (2017-2030)
12.2.8.2. Market Revenue and Forecast, by End User (2017-2030)
12.2.8.3. Market Revenue and Forecast, by Modality (2017-2030)
12.2.8.4. Market Revenue and Forecast, by Distribution Channel (2017-2030)
12.3. APAC
12.3.1. Market Revenue and Forecast, by Technology (2017-2030)
12.3.2. Market Revenue and Forecast, by End User (2017-2030)
12.3.3. Market Revenue and Forecast, by Modality (2017-2030)
12.3.4. Market Revenue and Forecast, by Distribution Channel (2017-2030)
12.3.5. India
12.3.5.1. Market Revenue and Forecast, by Technology (2017-2030)
12.3.5.2. Market Revenue and Forecast, by End User (2017-2030)
12.3.5.3. Market Revenue and Forecast, by Modality (2017-2030)
12.3.5.4. Market Revenue and Forecast, by Distribution Channel (2017-2030)
12.3.6. China
12.3.6.1. Market Revenue and Forecast, by Technology (2017-2030)
12.3.6.2. Market Revenue and Forecast, by End User (2017-2030)
12.3.6.3. Market Revenue and Forecast, by Modality (2017-2030)
12.3.6.4. Market Revenue and Forecast, by Distribution Channel (2017-2030)
12.3.7. Japan
12.3.7.1. Market Revenue and Forecast, by Technology (2017-2030)
12.3.7.2. Market Revenue and Forecast, by End User (2017-2030)
12.3.7.3. Market Revenue and Forecast, by Modality (2017-2030)
12.3.7.4. Market Revenue and Forecast, by Distribution Channel (2017-2030)
12.3.8. Rest of APAC
12.3.8.1. Market Revenue and Forecast, by Technology (2017-2030)
12.3.8.2. Market Revenue and Forecast, by End User (2017-2030)
12.3.8.3. Market Revenue and Forecast, by Modality (2017-2030)
12.3.8.4. Market Revenue and Forecast, by Distribution Channel (2017-2030)
12.4. MEA
12.4.1. Market Revenue and Forecast, by Technology (2017-2030)
12.4.2. Market Revenue and Forecast, by End User (2017-2030)
12.4.3. Market Revenue and Forecast, by Modality (2017-2030)
12.4.4. Market Revenue and Forecast, by Distribution Channel (2017-2030)
12.4.5. GCC
12.4.5.1. Market Revenue and Forecast, by Technology (2017-2030)
12.4.5.2. Market Revenue and Forecast, by End User (2017-2030)
12.4.5.3. Market Revenue and Forecast, by Modality (2017-2030)
12.4.5.4. Market Revenue and Forecast, by Distribution Channel (2017-2030)
12.4.6. North Africa
12.4.6.1. Market Revenue and Forecast, by Technology (2017-2030)
12.4.6.2. Market Revenue and Forecast, by End User (2017-2030)
12.4.6.3. Market Revenue and Forecast, by Modality (2017-2030)
12.4.6.4. Market Revenue and Forecast, by Distribution Channel (2017-2030)
12.4.7. South Africa
12.4.7.1. Market Revenue and Forecast, by Technology (2017-2030)
12.4.7.2. Market Revenue and Forecast, by End User (2017-2030)
12.4.7.3. Market Revenue and Forecast, by Modality (2017-2030)
12.4.7.4. Market Revenue and Forecast, by Distribution Channel (2017-2030)
12.4.8. Rest of MEA
12.4.8.1. Market Revenue and Forecast, by Technology (2017-2030)
12.4.8.2. Market Revenue and Forecast, by End User (2017-2030)
12.4.8.3. Market Revenue and Forecast, by Modality (2017-2030)
12.4.8.4. Market Revenue and Forecast, by Distribution Channel (2017-2030)
12.5. Latin America
12.5.1. Market Revenue and Forecast, by Technology (2017-2030)
12.5.2. Market Revenue and Forecast, by End User (2017-2030)
12.5.3. Market Revenue and Forecast, by Modality (2017-2030)
12.5.4. Market Revenue and Forecast, by Distribution Channel (2017-2030)
12.5.5. Brazil
12.5.5.1. Market Revenue and Forecast, by Technology (2017-2030)
12.5.5.2. Market Revenue and Forecast, by End User (2017-2030)
12.5.5.3. Market Revenue and Forecast, by Modality (2017-2030)
12.5.5.4. Market Revenue and Forecast, by Distribution Channel (2017-2030)
12.5.6. Rest of LATAM
12.5.6.1. Market Revenue and Forecast, by Technology (2017-2030)
12.5.6.2. Market Revenue and Forecast, by End User (2017-2030)
12.5.6.3. Market Revenue and Forecast, by Modality (2017-2030)
12.5.6.4. Market Revenue and Forecast, by Distribution Channel (2017-2030)
Chapter 13. Company Profiles
13.1. Abbott Laboratories
13.1.1. Company Overview
13.1.2. Product Offerings
13.1.3. Financial Performance
13.1.4. Recent Initiatives
13.2. Medtronic plc
13.2.1. Company Overview
13.2.2. Product Offerings
13.2.3. Financial Performance
13.2.4. Recent Initiatives
13.3. F. Hoffmann-La Roche Ltd.
13.3.1. Company Overview
13.3.2. Product Offerings
13.3.3. Financial Performance
13.3.4. Recent Initiatives
13.4. Ascensia Diabetes Care
13.4.1. Company Overview
13.4.2. Product Offerings
13.4.3. Financial Performance
13.4.4. Recent Initiatives
13.5. Dexcom, Inc.
13.5.1. Company Overview
13.5.2. Product Offerings
13.5.3. Financial Performance
13.5.4. Recent Initiatives
13.6. Sanofi Novo Nordisk
13.6.1. Company Overview
13.6.2. Product Offerings
13.6.3. Financial Performance
13.6.4. Recent Initiatives
13.7. Abbott
13.7.1. Company Overview
13.7.2. Product Offerings
13.7.3. Financial Performance
13.7.4. Recent Initiatives
13.8. Ypsomed Holdings
13.8.1. Company Overview
13.8.2. Product Offerings
13.8.3. Financial Performance
13.8.4. Recent Initiatives
13.9. Glysens Incorporated
13.9.1. Company Overview
13.9.2. Product Offerings
13.9.3. Financial Performance
13.9.4. Recent Initiatives
Chapter 14. Research Methodology
14.1. Primary Research
14.2. Secondary Research
14.3. Assumptions
Chapter 15. Appendix
15.1. About Us
15.2. Glossary of Terms
Why should you invest in this report?
If you are aiming to enter the global non-invasive blood glucose monitoring system market, this report is a comprehensive guide that provides crystal clear insights into this niche market. All the major application areas for non-invasive blood glucose monitoring system are covered in this report and information is given on the important regions of the world where this market is likely to boom during the forecast period of 2022-2030 so that you can plan your strategies to enter this market accordingly.
Besides, through this report, you can have a complete grasp of the level of competition you will be facing in this hugely competitive market and if you are an established player in this market already, this report will help you gauge the strategies that your competitors have adopted to stay as market leaders in this market. For new entrants to this market, the voluminous data provided in this report is invaluable.
Contact Us:
Mr. Alex
Sales Manager
Call: +1 9197 992 333
Email: sales@precedenceresearch.com
Web: https://www.precedenceresearch.com
Blog: https://www.pharma-geek.com
